Cannabinoid type 1 receptor in noradrenergic/adrenergic cells and its role in metabolism and stress

被引：0
|
作者：
Lutz, B.
机构：
来源：
ACTA PHYSIOLOGICA | 2014年 / 211卷
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
S4-B2
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [21] Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
    Ayat Zagzoog
    Asher L. Brandt
    Tallan Black
    Eunhyun D. Kim
    Riley Burkart
    Mikin Patel
    Zhiyun Jin
    Maria Nikolaeva
    Robert B. Laprairie
    Scientific Reports, 11
  • [22] Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
    Zagzoog, Ayat
    Brandt, Asher L.
    Black, Tallan
    Kim, Eunhyun D.
    Burkart, Riley
    Patel, Mikin
    Jin, Zhiyun
    Nikolaeva, Maria
    Laprairie, Robert B.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
    M A Steiner
    K Wanisch
    K Monory
    G Marsicano
    E Borroni
    H Bächli
    F Holsboer
    B Lutz
    C T Wotjak
    The Pharmacogenomics Journal, 2008, 8 : 196 - 208
  • [24] Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
    Steiner, M. A.
    Wanisch, K.
    Monory, K.
    Marsicano, G.
    Borroni, E.
    Baechli, H.
    Holsboer, F.
    Lutz, B.
    Wotjak, C. T.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (03): : 196 - 208
  • [25] Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1
    Marsicano, G
    Moosmann, B
    Hermann, H
    Lutz, B
    Behl, C
    JOURNAL OF NEUROCHEMISTRY, 2002, 80 (03) : 448 - 456
  • [26] URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels
    Ebrahimi-Ghiri, Mohaddeseh
    Khakpai, Fatemeh
    Zarrindast, Mohammad-Reza
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (07) : 875 - 884
  • [27] Adipose cannabinoid receptor type 1 in human obesity
    Engeli, S
    Feldpausch, M
    Gorzelniak, K
    Janke, J
    Luft, FC
    Sharma, AM
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S98 - S98
  • [28] Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling
    Laprairie, Robert B.
    Mohamed, Kawthar A.
    Zagzoog, Ayat
    Kelly, Melanie E. M.
    Stevenson, Lesley A.
    Pertwee, Roger
    Denovan-Wright, Eileen M.
    Thakur, Ganesh A.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [29] The future of type 1 cannabinoid receptor allosteric ligands
    Alaverdashvili, Mariam
    Laprairie, Robert B.
    DRUG METABOLISM REVIEWS, 2018, 50 (01) : 14 - 25
  • [30] The role of cannabinoid 1 receptor expressing interneurons in behavior
    Brown, Jacquelyn A.
    Horvath, Szatmar
    Garbett, Krassimira A.
    Schmidt, Martin J.
    Everheart, Monika
    Gellert, Levente
    Ebert, Philip
    Mirnics, Karoly
    NEUROBIOLOGY OF DISEASE, 2014, 63 : 210 - 221
12345